Severe psoriasis, morbid obesity and bariatric surgery

Clinical and Experimental Dermatology

Volumn 34, Issue 7, 2009, Pages

  Perez Perez L ^a   Allegue, F ^a   Caeiro, J L ^a   Fabeiro A Zulaica, J M ^a  

^a UNIVERSITY HOSPITAL COMPLEX OF VIGO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; EFALIZUMAB; ETRETIN; INFLIXIMAB; METHOTREXATE; VITAMIN D DERIVATIVE;

ADULT; BARIATRIC SURGERY; CASE REPORT; CLINICAL FEATURE; COMORBIDITY; DISEASE SEVERITY; FEMALE; HUMAN; LETTER; MORBID OBESITY; PRIORITY JOURNAL; PSORIASIS; QUALITY OF LIFE; TREATMENT RESPONSE; ULTRAVIOLET RADIATION;

BARIATRIC SURGERY; FEMALE; HUMANS; MIDDLE AGED; OBESITY, MORBID; PSORIASIS;

EID: 70349519243     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2009.03406.x     Document Type: Letter

References (6)

1. Sterry W, Strober BE, Menter A. Obesity in psoriasis. the metabolic, clinical and therapeutic implications. Report on an interdisciplinary conference and review. Br J Dermatol 2007 157 : 649 655.
2. Kimball AB, Gladman D, Gelfand JM et al. National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol 2008 58 : 1031 1042.
3. Higa-Sansone G, Szomstein S, Soto F et al. Psoriasis remission after laparoscopic roux-en-Y gastric bypass for morbid obesity. Obes Surg 2004 14 : 1132 1134. (Pubitemid 39299743)
4. Ettinger JE, Azaro E, Marcilio de Souza C et al. Remission of psoriasis after open gastric bypass. Obes Surg 2006 16 : 94 7.
5. Grundy SM, Brewer HB Jr., Cleeman JI et al. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004 109 : 433 438.
6. Cheymol C. Effects of obesity in pharmacokinetics. Implications for drug therapy. Clin Pharmacokinet 2000 39 : 215 231.